Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ResMed (NYSE:RMD) through any online brokerage.
Other companies in ResMed’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
ResMed has a consensus price target of $245.53.
The stock price for ResMed (NYSE: RMD) is $218.89 last updated October 2, 2026 at 5:55 PM EDT.
There are no upcoming dividends for ResMed.
ResMed does not have any upcoming earnings scheduled.
There is no upcoming split for ResMed.
ResMed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.